Usio : Partners with Voyager Digital to Enable Merchants and ISVs to Accept Cryptocurrency as a Form of Payment marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Usio to Participate in the Barrington Research Virtual Spring Investment Conference
May 24, 2021 09:00 ET | Source: Usio, Inc. Usio, Inc. San Antonio, Texas, UNITED STATES
SAN ANTONIO, May 24, 2021 (GLOBE NEWSWIRE) Usio, Inc: (Nasdaq: USIO), a leading FinTech integrated payment solutions provider, today announced it will participate in the Barrington Research Virtual Spring Investment Conference on Thursday, May 27, 2021. Louis Hoch, Chief Executive Officer, Greg Carter, Senior Vice President, Payment Facilitation and Houston Frost, Senior Vice President, Prepaid Services, will host virtual one-on-one and small group meetings throughout the day.
About Usio, Inc.
Usio, Inc. (Nasdaq: USIO), a leading FinTech integrated payment solutions provider, offers a wide range of payment solutions to merchants, billers, banks, service bureaus, crypto exchanges and card issuers. The Company operates credit, debit/prepaid, and ACH paym
Share this article
Share this article
ENGLEWOOD, Colo., May 10, 2021 /PRNewswire/ Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions for which there are limited treatment options, today announced that it has received Investigational Review Board (IRB) approval to commence enrollment in its AP-018 Phase I study using inhaled Ampion™ with patients exhibiting prolonged respiratory COVID-19 symptoms, known as long (or long-haul) COVID, or Post-Acute Sequelae of SARS-CoV-2. This trial is both needed and exciting in that it addresses a major current and expected ongoing unmet medical need among the estimated 3 to 10 million individuals currently suffering from long COVID, said Michael Macaluso, President and CEO of Ampio.
Veteran IR Executive Has Led Gregory FCA's Investor Relations Work for 15 Years The National Investor Relations Institute (NIRI) has announced that Senior .
Ampio Pharmaceuticals Provides Updates on Clinical Programs for Ampion™ in Osteoarthritis and COVID-19 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.